1. Near-Infrared Light-Triggered Unfolding Microneedle Patch for Minimally Invasive Treatment of Myocardial Ischemia
- Author
-
Xiaozhu Liao, Yuan Wei, Luyi Sun, Bin Liu, Zhengrong Yin, Zengjie Fan, Feng-Zhen Liu, and Haofei Huang
- Subjects
Male ,Vascular Endothelial Growth Factor A ,Myocardial ischemia ,Materials science ,Nir light ,Infrared Rays ,VEGF receptors ,Myocardial Infarction ,Cell Line ,Mice ,Drug Delivery Systems ,medicine ,Animals ,General Materials Science ,Myocardial infarction ,Fixation (histology) ,Near infrared light ,biology ,medicine.disease ,Rats ,Drug Liberation ,Needles ,Polyvinyl Alcohol ,Invasive surgery ,biology.protein ,Graphite ,Myocardial fibrosis ,Biomedical engineering - Abstract
It is hard to achieve safe, effective, and minimally invasive therapies on myocardial infarction (MI) via conventional treatments. To address this challenge, a vascular endothelial growth factor (VEGF)-loaded and near-infrared (NIR)-triggered self-unfolding graphene oxide (GO)-poly(vinyl alcohol) (PVA) microneedle (MN) patch was designed and fabricated to treat MI through a minimally invasive surgery (MIS). The folded MN patch can be easily placed into the chest cavity through a small cut (4 mm) and quickly recover to its original shape with 10 s of irradiation of NIR light (1.5 W/cm2, beam diameter = 0.5 cm), thanks to its excellent shape memory effect and fast shape recovery ability. Meanwhile, the unfolded MN patch can be readily punctured into the heart and wrap the heart tightly, thanks to its sufficient mechanical strength and adjustable morphological structure, thus ensuring a high fixation strength to withstand the high-frequency pulsation of the heart. In addition, the prepared MN patch has low cytotoxicity and controllable and sustainable release of VEGF. More importantly, the MN patch can effectively promote neovascularization, reduce myocardial fibrosis, and restore cardiac function, which indicates its promising application prospects in MIS.
- Published
- 2021
- Full Text
- View/download PDF